02 May 2003
PARP-1-induced cell death requires NAD+ depletion and mitochondrial permeability transition
R. Swanson, C. Alano, W. YingMed Sci Monit 2003; 9(1): 66- :: ID: 15205
Abstract
Mitochondrial permeability transition (MPT) leads to cell death in ischemia and inflammation [1]. Here we show that PARP-1 causes cell death through a process involving NAD+ depletion and mitochondrial permeability transition. PARP-1 activation in cultured mouse neurons or astrocytes led to delayed mitochondrial membrane depolarization and to MPT. These changes were prevented in PARP-1 deficient cells, with PARP inhibitors, or with sub-micromolar concentrations of MPT inhibitors, but not by the calcineurin inhibitor FK506. PARP-1-induced cell death was similarly blocked by MPT inhibitors but not FK506. Translocation of AIF from mitochondria to the nucleus, which has previously been linked PARP-1-induced cell death [2], did not occur when MPT was prevented. Last, repletion of intracellular NAD+ concentrations in PARP-1 activated cells prevented MPT, AIF translocation, and cell death. These results suggest that the NAD+ depletion is an upstream event in the PARP-1 cell death pathway, with NAD+ depletion leading to MPT, and MPT in turn leading to AIF translocation and cell death. References: 1.Halestrap AP: The mitochondrial permeability transition: its molecular mechanism and role in reperfusion injury. Biochem Soc Symp, 1999; 66: 181-203 2.Yu SW, Wang H, Poitras MF et al: Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science, 2002; 297: 259-263
Keywords: AIF, nicotinamide adenine dinucleotide, cyclosporin, membrane potential
Editorial
01 March 2023 : Editorial
Editorial: Global Surveillance of Highly Pathogenic Avian Influenza Viruses in Poultry, Wild Birds, and Mammals to Prevent a Human Influenza PandemicDOI: 10.12659/MSM.939968
Med Sci Monit 2023; 29:e939968
SARS-CoV-2/COVID-19
29 March 2023 : Editorial
Editorial: Effective Direct-Acting Antiviral Treatments Support Global and National Programs to Eliminate H...Med Sci Monit In Press; DOI: 10.12659/MSM.940519
30 March 2023 : Clinical Research
An Online Survey on the Relationship Between Positive Coping and Post-Traumatic Stress Symptoms (PTSS) of M...Med Sci Monit In Press; DOI: 10.12659/MSM.939485
09 February 2023 : Clinical Research
Evaluation of Health-Related Quality of Life and Mental Health in 729 Medical Students in Indonesia During ...Med Sci Monit 2023; 29:e938892
19 January 2023 : Clinical Research
Determining the Impact of the COVID-19 Pandemic on Dental Care in the Serbian Adult Population: An Online Q...Med Sci Monit 2023; 29:e939238
In Press
30 Mar 2023 : Clinical Research
An Online Survey on the Relationship Between Positive Coping and Post-Traumatic Stress Symptoms (PTSS) of M...Med Sci Monit In Press; DOI: 10.12659/MSM.939485
30 Mar 2023 : Database Analysis
Global Research Trends and Hotspots in Lateral Epicondylitis During the Past 30 Years: A Bibliometric and V...Med Sci Monit In Press; DOI: 10.12659/MSM.939309
29 Mar 2023 : Editorial
Editorial: Effective Direct-Acting Antiviral Treatments Support Global and National Programs to Eliminate H...Med Sci Monit In Press; DOI: 10.12659/MSM.940519
29 Mar 2023 : Laboratory Research
Preparation, Physicochemical Properties, and Structural Characterization of Resistant Starch-Aspirin-Loaded...Med Sci Monit In Press; DOI: 10.12659/MSM.939711
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952